Search Within

Department of Medicine

Formats
  1. Journal Article (19617)
  2. Meeting Abstract (16046)
  3. Review (1158)
  4. Book Section (934)
  5. Editorial (610)
  6. Research Letter (316)
  7. Conference Paper (301)
  8. Guidelines (298)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22346)
  2. Hematologic Malignancies, Division of (13287)
  3. Center for Hematologic Malignancies (11069)
  4. GSK Faculty (10651)
  5. Survivorship Research (9346)
  6. Division of Subspecialty Medicine (7554)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1133)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (906)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1116)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2291)
  6. Nature Publishing Group (2119)

More Publishers

Results (39667)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Gene expression differences between paired primary and metastatic breast carcinomas
    Meeting Abstract

    Giri, D.; Donaton, M.; Olshen, A.; Panageas, K.; Lal, P.; Levcovici, S.; Brogi, E.; Hudis, C.; Van Zee, K.; Tan, L.; more...
    Laboratory Investigation (2003)

    Fulltext@MSK | Save
  • Utilization of rituximab therapy in patients (pts) with newly diagnosed follicular (FL) and diffuse large B cell (DLCL) non-Hodgkin's lymphoma (NHL) in the United States: An analysis from the national comprehensive cancer network (NCCN) NHL outcomes project
    Meeting Abstract

    Friedberg, J. W.; Lepisto, E.; Rodriguez, M. A.; Ottensen, R.; LaCasce, A. S.; Nademanee, A. P.; Millenson, M.; Czuczman, M.; Niland, J.; Zelenetz, A. D.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • MUC-1 mucin positive patients with diffuse large B-cell lymphoma, a poor prognostic factor for outcome
    Meeting Abstract

    Feldstein, J. T.; Houldsworth, J.; Olshen, A.; Goy, A.; Donnelly, G.; Gilles, F.; Chaganti, R. S. K.; Zelenetz, A. D.
    Blood (2003)

    Fulltext@MSK | Save
  • A randomized phase II trial of the tyrosine kinase inhibitor PKC412 in patients (pts) with acute myeloid leukemia (AML)/high-risk myelodysplastic syndromes (MDS) characterized by wild-type (WT) or mutated FLT3
    Meeting Abstract

    Estey, E. H.; Fisher, T.; Giles, F.; Feldman, E. J.; Ehninger, G.; Schiller, G. J.; Klimek, V. M.; Nimer, S. D.; De Angelo, D. J.; Gilliland, D. G.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • Hard rock arteries: A case of a post-operative complication
    Meeting Abstract

    Elshinawy, A. A.; White, D. A.; Stover, D. E.
    Chest (2003)

    Fulltext@MSK | Save
  • Phase I clinical results with MLN518, a novel FLT3 antagonist: Tolerability, pharmacokinetics, and pharmacodynamics
    Meeting Abstract

    De Angelo, D. J.; Stone, R. M.; Bruner, R. J.; Caligiuri, M. A.; Heaney, M. L.; Nimer, S. D.; Paquette, R.; Sawyers, C. L.; Lambing, J. L.; Lokker, N. A.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • Improved molecular design and immunization route of CD20 peptides induce antibody against human CD20 protein
    Meeting Abstract

    Dao, T.; Antczak, C.; Boutsalis, G.; Kou, C.; Jaggi, J.; Kappel, B.; Pinilla-Ibarz, J.; Scheinberg, D. A.
    Blood (2003)

    Fulltext@MSK | Save
  • The expression of osteoprotegerin co-localises with columnar cell change in human breast tissue
    Meeting Abstract

    Cross, S. S.; Van Poznak, C.; Hudis, C.; Holen, I.
    Journal of Pathology (2003)

    Fulltext@MSK | Save
  • Serious complications following unrelated donor marrow collection: Experiences of the National Marrow Donor Program (R)
    Meeting Abstract

    Confer, D. L.; Leitman, S. F.; Papadopoulos, E. B.; Price, T. H.; Stroncek, D. F.; Robinett, P.; Braem, B.
    Blood (2003)

    Fulltext@MSK | Save
  • Doxorubicin and dexamethasone (AD) followed by thalidomide and dexamethasone (TD) as initial therapy for symptomatic patients with multiple myeloma
    Meeting Abstract

    Comenzo, R. L.; Hassoun, H.; Reich, L.; Klimek, V.; Kewalramani, T.; Dhodapkar, M.; Drake, L.; Hedvat, C.; Teruya-Feldstein, J.; Fleisher, M.; more...
    Blood (2003)

    Fulltext@MSK | Save